In fact, siRNA-mediated abrogation of NG2/CSPG4 in human and animal xenograft models of glioblastoma retards tumour growth and suppresses its invasiveness [26] and mouse antibody 9.2.27 in combined immunotherapy with immune cells in GBM-bearing rats may mediate anti-tumour effects [27]. The gene discussed is CSPG4; the disease is neoplasm.